Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulvovaginal candidosis.

Jack D Sobel1

  • 1Department of Medicine, Wayne State University School of Medicine, Detroit, MI, USA. jsobel@med.wayne.edu

Lancet (London, England)
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Vulvovaginal candidosis (VVC) is a common infection. This review covers VVC epidemiology, pathogenesis, and management, highlighting diagnostic challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same author

State-of-the-Art Review: Managing Vulvovaginal Candidiasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Elevated vaginal heparan sulfate correlates with impaired neutrophil killing of <i>Candida albicans</i> in women with vulvovaginal candidiasis.

Infection and immunity·2026
Same author

Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis.

Journal of women's health (2002)·2025
Same author

A phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis.

American journal of obstetrics and gynecology·2025
Same author

Vulvovaginal Candidiasis Caused by Candida krusei (Pichia kudriavzevii ), Still a Formidable Challenge.

Journal of lower genital tract disease·2025
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Women's Health

Background:

  • Vulvovaginal candidosis (VVC) persists globally despite treatment advancements.
  • Host defense mechanisms against Candida in the vagina are poorly understood.
  • Pathogenic mechanisms of VVC remain unclear, hindering effective treatment.

Purpose of the Study:

  • To review the epidemiology of vulvovaginal candidosis.
  • To discuss the pathogenesis of Candida infections in the vaginal environment.
  • To explore current and future management strategies for VVC.

Main Methods:

  • Literature review of epidemiology, pathogenesis, and management of VVC.
  • Synthesis of existing knowledge on anti-Candida host defense.
  • Analysis of diagnostic challenges and their impact.

Related Experiment Videos

Main Results:

  • VVC affects diverse populations worldwide.
  • Key risk factors are recognized, but core pathogenic mechanisms are elusive.
  • Lack of rapid, simple diagnostics leads to misdiagnosis.

Conclusions:

  • Effective management of VVC requires a deeper understanding of pathogenesis.
  • Improved diagnostic tools are crucial to reduce over- and underdiagnosis.
  • Integrated approaches addressing epidemiology, pathogenesis, and diagnostics are needed.